Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-25 @ 1:04 AM
Study NCT ID:
NCT02425904
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-26
First Post:
2015-04-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01
Completion Date Type:
ESTIMATED
First Submit Date:
2015-04-18
First Submit QC Date:
None
Study First Post Date:
2015-04-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-24
Results First Submit QC Date:
None
Results First Post Date:
2022-02-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-24
Last Update Post Date:
2025-09-26
Last Update Post Date Type:
ESTIMATED